Dr. Thomas Copperman , MD
Ophthalmology โข Seattle, WA
1101 Madison St Ste 600
Seattle, WA 981041340
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Thomas Copperman is listed in NPPES under Ophthalmology.
-
NPI assigned on April 2, 2013; this date does not establish years in practice.
-
Published CMS data list 1,048 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 โ Established patient outpatient office visit: 195 service units.
- 99214 โ Established patient outpatient office visit: 188 service units.
- J3301 โ Injection, triamcinolone acetonide, not otherwise specified, 10 mg: 128 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 689 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Erythromycin (Erythromycin Base) โ 416 prescription fills, including refills.
- Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) โ 114 prescription fills, including refills.
- Methylprednisolone โ 70 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 7 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Ophthalmology in Seattle, WA (2024, 86 clinicians with data). Median for this group: 1,045. Middle half: 457 to 2,551.
Fewer Medicare Part B services than 65% of clinicians listed under Ophthalmology in Washington (2024, 317 clinicians with data). Median for this group: 1,884. Middle half: 785 to 3,622.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 737 in 2020 to 1,048 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
1101 Madison St Ste 600
Seattle, WA 981041340
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Evergreen Eye Center Pllc; Eye Associates Northwest Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Wright State University Boonshoft School Of Medicine
2013
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
442 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $205,186 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $154,842 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
714 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$19,336 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $677.34 across 17 records.
By nature of payment
- Food and Beverage: $677.34 across 17 records.
Reporting-company totals (3 largest of 5)
- Amgen Inc.: $281.01 across 1 record.
- Dompe US, Inc.: $234.19 across 8 records.
- SUN PHARMACEUTICAL INDUSTRIES INC.: $76.78 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
13 years (graduated 2013)
CMS Doctors and Clinicians data list 2013 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Copperman has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Copperman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Seattle and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Ophthalmology in Seattle, WA (2024, 86 clinicians with data). Median for this group: 1,045. Middle half: 457 to 2,551.
Fewer Medicare Part B services than 65% of clinicians listed under Ophthalmology in Washington (2024, 317 clinicians with data). Median for this group: 1,884. Middle half: 785 to 3,622.
Medicare-allowed amount
A higher Medicare-allowed amount than 60% of clinicians listed under Ophthalmology in Seattle, WA (2024, 86 clinicians with data). Median for this group: $117,775. Middle half: $37,967 to $302,490.
Close to the middle for clinicians listed under Ophthalmology in Washington (2024, 317 clinicians with data). Median for this group: $234,874. Middle half: $90,157 to $464,023.
Paid by Medicare
A higher Medicare payment amount than 60% of clinicians listed under Ophthalmology in Seattle, WA (2024, 86 clinicians with data). Median for this group: $84,293. Middle half: $27,691 to $216,342.
Close to the middle for clinicians listed under Ophthalmology in Washington (2024, 317 clinicians with data). Median for this group: $166,859. Middle half: $66,024 to $347,874.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in Seattle, WA (2024, 100 clinicians with data). Median for this group: 583. Middle half: 193 to 1,222.
Close to the middle for clinicians listed under Ophthalmology in Washington (2024, 352 clinicians with data). Median for this group: 714. Middle half: 258 to 1,541.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in Seattle, WA (2024, 100 clinicians with data). Median for this group: $42,117. Middle half: $7,531 to $111,901.
A lower Part D drug cost than 60% of clinicians listed under Ophthalmology in Washington (2024, 352 clinicians with data). Median for this group: $39,035. Middle half: $8,499 to $142,536.
147 active clinicians are listed under Ophthalmology with a practice address in Seattle, WA (523 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Seattle
4.1% of these 147 clinicians have the CMS telehealth indicator.
66% of these 147 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 42% from 737 in 2020 to 1,048 in 2024.
- 2020: 737
- 2021: 1,189
- 2022: 1,452
- 2023: 1,561
- 2024: 1,048
-
Medicare-allowed amount
Medicare-allowed amount increased 112% from $96,824 in 2020 to $205,186 in 2024.
- 2020: $96,824
- 2021: $173,892
- 2022: $200,413
- 2023: $249,861
- 2024: $205,186
-
Paid by Medicare
Paid by Medicare increased 109% from $74,231 in 2020 to $154,842 in 2024.
- 2020: $74,231
- 2021: $132,102
- 2022: $151,510
- 2023: $191,394
- 2024: $154,842
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 220% from 215 in 2020 to 689 in 2024.
- 2020: 215
- 2021: 526
- 2022: 538
- 2023: 680
- 2024: 689
-
30-day fills
30-day fills increased 202% from 236 in 2020 to 714 in 2024.
- 2020: 236
- 2021: 569
- 2022: 560
- 2023: 691
- 2024: 714
-
Part D drug cost
Part D drug cost increased 276% from $5,146 in 2020 to $19,336 in 2024.
- 2020: $5,146
- 2021: $8,147
- 2022: $7,543
- 2023: $9,369
- 2024: $19,336
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $80.96 in 2021 to $677.34 in 2025.
- 2021: $80.96
- 2022: $221.60
- 2023: $341.00
- 2024: $259.57
- 2025: $677.34
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 17 records totaling $677.34.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEPEZZA | General | $281.01 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $33.93 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $33.20 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $33.14 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $29.79 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $28.33 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $26.94 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $26.53 |
| Thea Pharma Inc. |
Food and Beverage
In-kind items and services
|
IYUZEH | General | $24.92 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
MIEBO | General | $23.95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $22.94 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $22.33 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
XIIDRA | General | $21.32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $19.11 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $17.49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $17.24 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
VYZULTA | General | $15.17 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
195 | 153 | $295.00 | $99.40 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
188 | 174 | $416.00 | $140.76 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
128 | 15 | $6.75 | $0.93 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
94 | 94 | $539.00 | $182.21 |
|
68840
Probing of nasal tear duct
|
92 | 71 | $670.58 | $183.27 |
|
67917
Extensive repair of turning-outward eyelid defect
|
50 | 44 | $1995.26 | $419.58 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
50 | 50 | $365.00 | $122.57 |
|
67840
Removal of growth of eyelid
|
41 | 38 | $987.51 | $312.15 |
|
15823
Removal of excessive skin and fat of upper eyelid
|
38 | 38 | $3356.32 | $892.46 |
|
67903
Shortening or advancement of upper eyelid muscle to correct drooping or paralysis
|
29 | 29 | $2583.72 | $699.51 |
|
68815
Probing of nasal tear duct with insertion of tube or stent
|
20 | 19 | $1808.80 | $465.34 |
|
68440
Snip incision of tear duct at inner corner of eye
|
19 | 17 | $463.16 | $74.68 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
18 | 18 | $187.00 | $63.04 |
|
92285
Photography of content of eyes
|
17 | 17 | $81.00 | $27.32 |
|
67700
Incision and drainage of abscess of eyelid
|
16 | 15 | $994.00 | $328.86 |
|
11900
Injection into skin growth, 1-7 growths
|
14 | 14 | $194.00 | $58.20 |
|
67875
Temporary closure of eyelids by suture
|
14 | 11 | $308.00 | $51.95 |
|
67904
Repair of tendon of upper eyelid
|
13 | 13 | $2723.38 | $773.37 |
|
31231
Diagnostic exam of nasal passages using an endoscope
|
12 | 11 | $657.00 | $162.10 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Erythromycin | Erythromycin Base | 416 | 5,819 | $4,517.94 | 287 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 114 | 2,409 | $1,210.55 | 103 |
| Methylprednisolone | Methylprednisolone | 70 | 417 | $444.09 | 62 |
| Prednisolone Acetate | Prednisolone Acetate | 47 | 1,540 | $1,497.01 | 43 |
| Restasis | Cyclosporine | 16 | 540 | $11,433.03 | โ |
| Bacitracin-Polymyxin | Bacitracin/Polymyxin B Sulfate | 15 | 186 | $194.84 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | 81 | $38.39 | 11 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-06-03NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0200X
A physician who specializes in oculofacial plastic and reconstructive surgery. This subspecialty combines orbital and periocular surgery with facial plastic surgery, and includes aesthetic and reconstructive surgery of the face, orbit, eyelid, and lacrimal system. Practitioners evaluate, diagnose and treat conditions involving the eyelids, brows, midface, orbits, lacrimal systems and surrounding and supporting structures of the face and neck.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20200323003295
WA
9739323585
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Evergreen Eye Center Pllc
1455 Nw Leary Way, Seattle, WA 981075138
Phone: 2067843350
Evergreen Eye Center Pllc
1101 Madison St, Seattle, WA 981043501
Phone: 2062152020
Evergreen Eye Center Pllc
34719 6th Ave S, Federal Way, WA 980038714
Phone: 2062122100
Eye Associates Northwest Pllc
1101 Madison St, Seattle, WA 981043501
Phone: 2062152020
Evergreen Eye Center Pllc
11325 Ne 120th St, Kirkland, WA 980346907
Phone: 4258216655
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Osteopathic Medicine (D.O.)
Optometrist
Doctor of Optometry
Optometrist
Doctor of Optometry
Ophthalmology
Doctor of Medicine (M.D.)
Optometrist
Doctor of Optometry
Optometrist
Doctor of Optometry
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1101 MADISON ST STE 600, SEATTLE, WA 981041340 (Tel: 2062152020)
Registered at 1101 MADISON ST STE 600, SEATTLE, WA 981041340 (Tel: 2062152020)
Recorded as THOMAS COPPERMAN, MD
Ophthalmology (license number reported to NPPES: WA MD61042379)
Registered at 692 RITCHIE HWY STE 2B, SEVERNA PARK, MD 211463919 (Tel: 4106470123)
Registered at 692 RITCHIE HWY STE 2B, SEVERNA PARK, MD 211463919 (Tel: 4106470123)
Ophthalmology (license number reported to NPPES: MD D0086949)
Ophthalmology (license number reported to NPPES: CA 148638)
Ophthalmology (license number reported to NPPES: MA 259508)
NPI status registered as active in NPPES database
Registered at 400 PARNASSUS AVE, SAN FRANCISCO, CA 941432202 (Tel: 4154761000)
Registered at 10 KORET WAY, SAN FRANCISCO, CA 94131
Recorded as THOMAS COPPERMAN, M.D.
Ophthalmology (license number reported to NPPES: CA 148638)
NPI status registered as active in NPPES database
Registered at 850 HARRISON AVE, YAWKEY BUILDING FLOOR 3, BOSTON, MA 021184001 (Tel: 6174144020)
Registered at 850 HARRISON AVE, YAWKEY BUILDING FLOOR 2, BOSTON, MA 021184001
Recorded as THOMAS COPPERMAN, M.D.
Ophthalmology (license number reported to NPPES: MA 259508)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Seattle
- Dr. Agnes Huang, MD
- Dr. Philip Chen, MD
- Dr. Thomas Gillette, MD
- Dr. Eun Huh, MD
- Dr. Grant Howell, MD
- Dr. Lee Kiang, MD, PhD
Mailing Address
1101 Madison St Ste 600
Seattle, WA 981041340
Phone: 2062152020